Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 17 clinical trials
featured
Do You Take Two Insulins to Treat Your Type 2 Diabetes?

: Basal insulin: Lantus or Basaglar (Glargine) Bolus insulin: Humalog (Lispro), Novolog (Aspart), or Apidra (Glulisine). With or without up to 3 of the following:

  • 0 views
  • 26 Feb, 2021
  • 1 location
featured
Weekly Basal Insulin - Allowing More Flexibility With Treating Type 1 Diabetes. (In the Greater Seattle Area.)

take Insulin Degludec (Tresiba) administered by insulin pen. All participants would switch to Insulin Aspart (Novolog) administered by insulin pen. Participants must be willing to check their blood

insulin
sugars
hemoglobin a1c
  • 0 views
  • 11 Jun, 2021
  • 1 location
Diluted Insulin in Young Children: Bigger Volumes for Smaller Patients

The aim of this study is to compare the pharmacokinetic (PK) profile of diluted insulin aspart (U25) with undiluted insulin aspart (U100) in school-aged children and adolescents with type 1

  • 0 views
  • 19 Mar, 2021
  • 1 location
Effect of Postprandial Insulin Administration of Faster-acting Insulin Analogue Versus Pre-prandial Administration of Acting-insulin Analogue in Cystic Fibrosis Related Diabetes

insulins mimicking the physiological secretion more closely has led to ultra-fast insulins (fast aspart), allowing for postprandial hyperglycaemia to be better controlled. In Type 1 diabetics treated with

  • 0 views
  • 25 Jan, 2021
  • 1 location
Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.

The purpose of the project is to shown whether a little dose of a short acting insulin analogue given 3 time daily before the meals compared with placebo could normalise the increase in blood glucose after teh meals in diet treated Type 2 diabetic patients.

fasting
fasting blood glucose
  • 1 views
  • 07 Nov, 2020
  • 1 location
Fast-Acting Insulin Aspart and Insulin Pump Settings

To clarify the role of fast-acting insulin aspart (Fiasp) in insulin pump-treated type 1 diabetes more research is needed. The aim of this study is twofold: to compare the

  • 0 views
  • 21 Feb, 2021
  • 1 location
Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes

Fast-acting insulin aspart (faster aspart) will be tested to see how well it works and if it is safe. The study compares 2 medicines for type 1 and type 2 diabetes - faster aspart (a new

  • 0 views
  • 30 May, 2021
  • 24 locations
Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes

recommended method to reduce exercise-associated hypoglycemic risk. The impact of faster acting Aspart (FiAsp) pharmacokinetic on hypoglycemic risk has not yet been explored. This study will explore two

hypoglycaemic
fiasp
treatment regimen
hypoglycemia
diabetes
  • 8 views
  • 13 May, 2021
  • 2 locations
Fast Advanced Closed-Loop Therapy

Faster Insulin Aspart to Standard Insulin Aspart therapy over 4 weeks in active children and adolescents with type 1 diabetes.

insulin
diabetes
hemoglobin a1c
  • 0 views
  • 21 May, 2021
  • 2 locations
A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 Diabetes

This study looks at how faster aspart reaches and stays in the blood after injection in Chinese people with type 1 diabetes or type 2 diabetes, compared to the reference product called NovoRapid

  • 0 views
  • 28 Apr, 2021
  • 1 location